DUALITY ADVISERS, LP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.

Quarter-by-quarter ownership
DUALITY ADVISERS, LP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,068,000
-12.3%
48,943
+20.1%
0.12%
+24.7%
Q3 2021$1,218,000
+16.3%
40,763
+72.8%
0.09%
+2.2%
Q1 2021$1,047,000
+347.4%
23,589
+130.4%
0.09%
+506.7%
Q3 2020$234,00010,2400.02%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,812,491$234,534,00010.10%
TANG CAPITAL MANAGEMENT LLC 2,965,485$41,369,0005.81%
Ghost Tree Capital, LLC 650,000$9,068,0002.40%
Boxer Capital, LLC 1,466,051$20,451,0001.39%
Vivo Capital, LLC 860,648$12,006,0001.09%
Samsara BioCapital, LLC 128,197$1,788,0001.03%
Cormorant Asset Management, LP 1,568,550$21,881,0001.02%
Perceptive Advisors 2,189,010$30,537,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,677,367$23,399,0000.74%
Eventide Asset Management 1,415,000$19,739,0000.64%
View complete list of ROCKET PHARMACEUTICALS INC shareholders